Product Image

Ginkgo+

NS Natural Stacks
4.7
★ ★ ★ ★ ★
(87 ratings)
Ginkgo
Bacopa 200 mg
Product Image
Score78
A coherent and affordable three-herb cognitive formula, limited by modest bacopa and missing active-marker percentages.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Cognitive Support
Brain Health
Mental Focus

Score 78

A coherent and affordable three-herb cognitive formula, limited by modest bacopa and missing active-marker percentages.
How scoring works
$19.13($0.31 per serving)
Walmart
$ 23.95
iHerb
$ 19.13
Report prices

Analysis

Ginkgo, bacopa, and Panax ginseng cover cerebral circulation, memory formation, and mental stamina. The short ingredient list is easier to understand than a large proprietary nootropic blend.

Ginkgo reaches a practical extract weight, but its flavone and terpene percentages are absent. Bacopa is below a preferred clinical amount and does not state its bacoside yield.

The formula fits long-term cognitive and focus routines better than vision support. Its low qualitative serving cost is attractive, though incomplete standardization keeps results less predictable.

Who is it for
  • Adults seeking a simple botanical cognitive stack
  • People who prefer non-caffeine focus support
Best for
  • Memory, circulation, and mental stamina
  • Long-term cognitive routines

Pros

  • Focused three-botanical formula
  • Ginkgo weight reaches common use
  • Covers complementary cognitive pathways
  • Favorable qualitative value

Cons

  • Bacopa amount is modest
  • Bacoside percentage is not stated
  • Ginkgo marker percentages are absent
  • Limited direct eye-support coverage

Warnings

  • Ginkgo may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Panax ginseng may affect blood pressure, heart rate, or sleep
  • Bacopa can cause digestive upset or drowsiness

Nutrient quality

85 Highest impact

Named active-marker classes and useful extract amounts support a high-quality cognitive blend. Missing marker percentages and purity limits keep exact active yields uncertain.

.

Ingredient transparency

73 High impact

Active amounts are clearly listed and no proprietary blend hides the supplied doses. Missing daily directions, excipients, and some form or potency details keep disclosure incomplete.

.

Customer satisfaction

64 Moderate impact

The supplied average is very strong, but the review base is only moderate. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.

.

Value for money

88 Highest impact

A coherent three-botanical formula and favorable serving cost support strong value. Incomplete marker percentages are the main limitation when comparing extract potency.

.
Report analysis

Goals

Cognitive Support
Impact
High effect
A- Goal FitC Strength of SupportB CoverageA- Formula Quality
Bacopa · 200 mg

Ginkgo, bacopa, and ginseng give the formula a direct connection to circulation, memory formation, and mental stamina. Human evidence is strongest for the ginkgo and bacopa components, although their extract quality is incompletely described.

The ginkgo amount is practical, while the bacopa amount is modest and neither extract states its active-marker percentage. The three-botanical stack is coherent, but people using anticoagulant or antiplatelet medicines should note that ginkgo may increase bleeding risk.

Study evidence
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Brain Health
Impact
High effect
B+ Goal FitC Strength of SupportB CoverageA- Formula Quality
Bacopa · 200 mg

Ginkgo, bacopa, and Panax ginseng create a clearly brain-oriented botanical formula. Ginkgo is practically dosed, while bacopa is below the preferred range and active-marker percentages are missing.

The combination may support circulation, memory, and mental energy, but uncertain standardization limits confidence in potency. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Impact
High effect
B+ Goal FitC Strength of SupportC+ CoverageA Formula Quality

Ginkgo, bacopa, and Panax ginseng form a focused botanical stack for circulation, memory, and mental stamina. Ginkgo reaches a useful extract weight, while bacopa is modest and neither herb discloses marker percentages.

The short formula balances several cognitive pathways without unnecessary general-health ingredients. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Productivity Boost
Impact
Moderate effect
B- Goal FitD Strength of SupportC- CoverageB Formula Quality

Ginkgo and Bacopa provide a clear foundation for productivity support. The supplied amounts do not establish strong targeted support.

Coverage reaches memory and neurotransmitter support and calm focus and stress resilience. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Impact
Moderate effect
F Goal FitC+ Strength of SupportD- CoverageB- Formula Quality

A 125 mg ginkgo extract may support ocular circulation, but it does not provide macular pigments, DHA, or the core antioxidant framework used in established eye formulas. Marker names are listed without their percentages, leaving standardized potency uncertain.

The focused botanical formula is easy to understand, though evidence for vision outcomes is limited and indirect. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Panax ginseng Root Extract (Ginsenosides)
200 mg
Bacopa monnieri Whole Plant Extract (Bacosides)
200 mg
Ginkgo biloba Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones)
125 mg
Adults 18–50
Report overview
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
Flavone glycoside and terpene lactone markers are named, but their percentages are not stated. 125 mg falls within the effective daily extract range. Missing marker percentages prevent a reliable standardized-dose cost comparison, while the well-dosed companion formula earns a limited premium adjustment. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.
Bacopa (Bacosides) · 200 mg OverallScore38
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyC Value

Whole-plant sourcing is clearly identified, but the label gives no bacoside percentage or named clinical extract. The 200 mg serving remains below the preferred clinical range, and its active yield cannot be calculated. Its low serving cost provides some value despite these quality and dose limitations.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  4. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  5. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  6. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis.
    Zhan M; Sun L; Liu J; Zeng Z; Shen W; Li H; Wang Y; Han F; Shi J; Zeng X; Lu X; Zhang Y; Liao X · Oxidative medicine and cellular longevity · 2022
    Meta-analysis2,019 participants23 studies pooledCognitive Support Brain Health forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost Cognitive Support forGinkgo
  8. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  9. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  10. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  11. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost Mental Focus forGinkgo
  12. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  13. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers.
    Kennedy DO; Scholey AB; Wesnes KA · Psychopharmacology · 2001
    Randomized trial20 participantsProductivity Boost forGinkgo
  14. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  15. Effect of single-dose Ginkgo biloba and Panax ginseng on driving performance.
    LaSala GS; McKeever RG; Patel U; Okaneku J; Vearrier D; Greenberg MI · Clinical toxicology (Philadelphia, Pa.) · 2015
    Randomized trial30 participantsProductivity Boost forGinkgo
  16. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  17. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.
    Hashiguchi M; Ohta Y; Shimizu M; Maruyama J; Mochizuki M · Journal of pharmaceutical health care and sciences · 2016
    Meta-analysis2,381 participants13 studies pooledCognitive Support Brain Health forGinkgo
  18. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  19. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Productivity Boost Mental Focus forBacopa
  20. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledBrain Health Mental Focus Cognitive Support forBacopa
  21. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsCognitive Support Brain Health forBacopa
  22. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewBrain Health Mental Focus forBacopa
  23. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
    Sathyanarayanan V; Thomas T; Einöther SJ; Dobriyal R; Joshi MK; Krishnamachari S · Psychopharmacology · 2013
    Randomized trial72 participantsProductivity Boost Mental Focus Brain Health forBacopa
  24. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.
    Nathan PJ; Clarke J; Lloyd J; Hutchison CW; Downey L; Stough C · Human psychopharmacology · 2019
    Randomized trial38 participantsBrain Health Cognitive Support forBacopa
  25. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.
    Crawford C; Boyd C; Deuster PA · Journal of alternative and complementary medicine (New York, N.Y.) · 2021
    Systematic review69 studies pooledBrain Health Productivity Boost forBacopa
  26. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus Productivity Boost forBacopa
  27. The efficacy of nutritional phytochemical compounds in improving cognition.
    Marsh A; Quelch D; Mackonochie M; Hejmadi M; Rolfe V · The international journal of neuropsychopharmacology · 2026
    Systematic review7 studies pooledMental Focus forBacopa
  28. Chronic effects of Brahmi (Bacopa monnieri) on human memory.
    Roodenrys S; Booth D; Bulzomi S; Phipps A; Micallef C; Smoker J · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2002
    Randomized trial76 participantsCognitive Support Mental Focus forBacopa
  29. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  30. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  31. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsProductivity Boost forBacopa
  32. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  33. The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lopresti AL; Smith SJ · Clinical drug investigation · 2025
    Randomized trial101 participantsProductivity Boost forBacopa
  34. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledCognitive Support Brain Health Mental Focus forBacopa
  35. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment.
    Raghav S; Singh H; Dalal PK; Srivastava JS; Asthana OP · Indian journal of psychiatry · 2011
    Randomized trialBrain Health Cognitive Support forBacopa
  36. The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data.
    Brimson JM; Brimson S; Prasanth MI; Thitilertdecha P; Malar DS; Tencomnao T · Scientific reports · 2021
    Meta-analysisCognitive Support forBacopa
  37. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  38. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  39. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  40. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  41. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  42. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  43. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  44. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  45. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  46. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  47. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  48. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  49. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  50. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  51. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  52. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  53. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  54. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  55. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  56. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo